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Abstract
Background: Depression during pregnancy or after childbirth is the most frequent perinatal illness affecting women
of reproductive age. It could result in unfavourable outcomes for both women and their newborns. The incidence of
perinatal depression is higher for those with family history of depression and other mental illness, suggesting the
contribution of genetic factors. There is postulation that disruption or fluctuation of reproductive hormones could play
a part in women who are sensitive to such changes.
Methods: This is a case-control study comparing the frequencies of candidate gene variants in patients with perinatal
depression with controls. Patients of Chinese descent (N = 725) were recruited from the outpatient clinics of the hospital
between 2010 and 2013. Controls were patients who came for postnatal consultations at the obstetrics clinics
and scored ≤ 7 on the Edinburgh Postnatal Depression Scale (EPDS) at the postnatal screening programme of the
hospital. Cases with confirmed diagnosis of clinical (major) depression related to pregnancy/postpartum were recruited
from the hospital’s outpatient clinic. Genomic DNA was extracted from saliva samples and genotyped for the
polymorphisms of interest. Differences between groups were assessed by chi-square analysis.
Results: CRHR1 rs242939 and rs1876828 were not polymorphic in the study population. There was no
statistically significant association of perinatal depression for CRHR1 rs242941 and GR rs41423247 (BclI). When all
subjects were grouped based on family history of mental illness, there was a statistically significant association of
CRHR1 rs242941 with family history regardless of depression status (P = 0.043). There was also a statistically significant
difference for GR rs41423247 and regularity of menstrual periods (P < 0.000). Although not statistically significant,
women with perinatal depression showed a trend towards higher frequency of self-reported menstrual irregularity.
Conclusions: No evidence was found for the association of any of the genetic markers with perinatal depression in this
study cohort. Instead, the possible genetic links were found in women with positive family history of mental illness and
menstrual irregularity, suggesting these could be identifying risk markers for women.
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Background
Depression is a complex heterogeneous disorder that
results from gene-environment interaction [1, 2]. Evidence
for genetic contribution comes from twin and family stud-
ies, which suggests a heritability of 30 – 70 % and a 3-fold
increased risk for first-degree relatives [3].
Depression affects all populations worldwide and is a
major cause of disability and loss of productivity. The
prevalence in women is higher than that of men. Women
of childbearing age have the highest risk of developing
depression, with close to 20 % suffering from postnatal
depression or having depressive symptoms during preg-
nancy [4, 5]. The prevalence of antenatal depression in
Singapore is between 12 % and 20 % and for postnatal
depression it is 6.8 % [6, 7]. This rate is close to the range
reported for western populations [8–10].
There is evidence that in some women, childbirth may
be a specific trigger for depressive illness. Previous studies
have proposed that the development of depression in some
women could be triggered by striking changes in hormonal
levels during pregnancy and following childbirth. These
hormones include oestrogen, progesterone, corticotrophin-
releasing hormone, cortisol and glucocorticoids [11–15].
In a genome-wide linkage study, the strongest signals that
may be specific to postpartum mood symptoms were on
1q21.3-q32.1 and 9p24.3-p22.3, with modest association
for Hemicentin gene SNPs on chromosome 1 [16]. The
gene might have oestrogen receptor binding sites and was
highly expressed in the hippocampus region. Drop in
oestrogen levels after a hormone-stimulated pregnancy has
been reported to alter hippocampal cell proliferation in
rats [17]. Among transcripts which showed different
expression patterns between women with postpartum
depression and euthymic women, there was enrichment of
those implicated in the oestrogen signalling pathway [18].
Disruption in ovarian function manifested as a change
in menstrual cycle length has been linked to higher
cardio-metabolic risk, higher scores for Center for
Epidemiological Studies Depression Scale, and higher
likelihood to have had a diagnosis of depression or used
anti-depressant medication [19]. A link between psychiatric
disorders and regularity of menstrual cycle has also been
found in Caucasian women [20].
Past history of depression and family history of mental
illness remain the two strongest predictors of perinatal
depression [21]. Given the role of the hypothalamic-
pituitary-adrenocortical (HPA) axis in the aetiology of
depression and the changing levels of corticotrophin-
releasing hormone (CRHR1) during pregnancy, it is likely
that the predisposition to perinatal depression might be
related to genetic polymorphisms in the hormone recep-
tors. Indeed, several studies have shown that polymor-
phisms at the glucocorticoid receptor (GR), such as BclI
and ER22/23EK were associated with dysfunction of the
HPA axis and altered glucocorticoid sensitivity leading to
depression [22–25]. Single nucleotide polymorphisms and
haplotypes of CRHR1 were also found to be significantly
over-represented in patients with major depression com-
pared to controls [26–28].
Several studies have looked into specific single nucleo-
tide polymorphisms (SNPs) of the glucocorticoid and
corticotrophin-releasing hormone receptor genes in rela-
tion to the risk of developing depression during preg-
nancy and the postnatal period. The results range from
none [29, 30] to very strong positive association with
risk ratios of 2.9 – 5.48 [31].
In this study, we investigated the five SNPs in the study
which showed high risk ratios [31] in a cohort of hospital
patients that included controls who had been screened for
postnatal depression and cases who met diagnostic criteria
for perinatal depression. Besides providing replication for
the positive association, our aim was also to obtain the
genotypic frequencies of the five SNPs, namely BclI
(rs41423247) and ER22/23EK (rs6189–6190) of GR; and




The study design was reviewed and approved by the
SingHealth Centralised Institutional Review Board which
oversees all research studies in the hospital. The investiga-
tion was carried out in accordance with the latest version
of the Declaration of Helsinki. Written informed consent
of the participants was obtained after the procedures had
been fully explained to them. The study sample has been
described in a previous report [32]. In short, cases were re-
cruited from outpatient psychiatric clinics and were all di-
agnosed by board-certified psychiatrists according to the
criteria in Diagnostic Statistical Manual of Mental Disor-
ders IV edition. Inclusion criteria for cases were being of
Chinese ancestry and having a confirmed diagnosis of clin-
ical (major) depression related to pregnancy/postpartum.
However, those with comorbid predominant anxiety,
psychotic disorders, or substance abuse were excluded
from the analysis. Controls were recruited from patients
who attended postnatal obstetrics clinics and were
screened for absence of symptoms of postnatal depression
using the Edinburgh Postnatal Depression Scale (EPDS).
Only those with EPDS score ≤ 7 and self-reported as being
Chinese were included. From a cohort of 725 subjects re-
cruited between November 2010 and March 2013, 147
cases and 549 controls of self-reported Chinese ancestry
were included in this study.
Data on demographics, personal and family history of
mental illness, menstrual cycle regularity and mood
changes were captured through in-person interviews based
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on a standard set of questions and recorded on a data col-
lection form at the time of recruitment.
Molecular analysis
DNA was extracted from saliva samples using either the
Oragene DNA Kit (DNA Genotek Inc., Kanata, Canada)
or the Norgen Saliva DNA collection kit (Norgen Biotek
Corp., Thorold, Canada). DNA was quantitated using
Nanodrop Spectrophotometer (Thermo Scientific, Wil-
mington, USA).
Genotyping of the three CRHR1 SNPs were done using
Taqman assays: rs242941 - Assay ID: AHLJYBU; rs242
939 - Assay ID: C__2544833_10, rs1876828 - Assay ID:
11935972_10. (Applied Biosystems, Foster City, CA,
USA). Amplification was performed in a volume of 12 μl
containing 25 ng genomic DNA, Taqman Universal
Polymerase Chain Reaction Master Mix, 60 nM of each
probe, and 270 nM of each primer. Cycling and
hybridization conditions were set according to manufac-
turer’s instructions. The 50 cycles of denaturation and
annealing/extension and post-polymerase chain reaction
quantification of fluorescent intensity were performed
using the Applied Biosystems StepOnePlus Real-Time
PCR System. Alleles were called using the sequence
detection software.
Genotyping of the GR BclI (rs41423247) was done by
polymerase chain reaction followed by restriction with
BclI and electrophoresis on 3 % agarose gel. Genotypes
were scored manually. No genotyping was performed for
GR ER22/23EK (rs6189–6190) because multiple studies
show that it is not polymorphic in the Chinese popula-
tion [33–35].
Statistical analysis
For genotype distribution, deviation from Hardy-Weinberg
equilibrium (HWE) was evaluated using a chi-square (χ2)
test. Difference in distribution of categorical variables
between groups was also assessed by χ2 test. All analysis
was performed using Statistical Package for the Social
Sciences (SPSS, IBM Corp., Armonk, NY, USA), version
19.0, with statistical significance set at 0.05.
Results
For two of the three polymorphisms investigated for the
CRHR1 gene, all samples that were genotyped (>100 indi-
viduals) for SNPs rs242939 and rs1876828 were homozy-
gous for the major allele (AA and CC respectively).
Genotyping was not performed for the remaining samples.
Genotyping error was ruled out by using samples of
Indian and Caucasian ancestry, with the successful detec-
tion of the minor alleles for both SNPs.
Results for the remaining two SNPs for cases and con-
trols are presented in Table 1. Genotyping was successful
for 99.7 % of the samples for CRHR1 rs242941 and
98.9 % for GR rs41423247. Genotype distributions for
both SNPs were in Hardy-Weinberg equilibrium. There
was no difference in the distribution between the case
and control groups.
When the diagnosis of depression was not considered,
there was a statistically significant association between
CRHR1 rs242941 and family history of mental illness
(Table 2); and between GR rs41423247 and regularity of
menstrual periods (Table 3). Among the cases with peri-
natal depression, there was a higher proportion (22.5 %)
who self-reported that their menstrual cycles were not
regular, compared to 17.3 % among controls; although
this was not statistically significant (χ2 = 3.123, P = 0.210).
Discussion
During pregnancy, the development of a transient organ
of foetal origin, the placenta, causes major alterations in
the hypothalamic-pituitary-adrenal (HPA) axis. It has
been suggested that HPA axis dysregulation during this
period of dramatic change in hormonal levels could
cause the development of postpartum depression in vul-
nerable women [36]. Life stress was also found to be an
important risk factor for depressive symptoms during
pregnancy in a systematic review of 57 studies [37].
Genes related to HPA axis and stress reactivity are thus
good candidate genes for perinatal depression.
A recent study by Engineer et al. found that the BclI
single nucleotide polymorphism of the GR gene and the
rs242939 SNP of the CRHR1 gene were associated with
genetic risk to antenatal and postnatal depression [31].
We found no evidence of an association between the GR
Table 1 Genotype distribution for controls and cases for the
two polymorphic variants
Gene Genotypes Controls (%) Cases (%) χ2 P-value
CRHR1 rs242941 GG 472 (86.0) 127 (86.4)
rs242941 GT 71 (12.9) 19 (12.9) 0.199 0.905
rs242941 TT 6 (1.1) 1 (0.7)
GR rs41423247 GG 326 (60.0) 88 (59.9)
rs41423247 GC 194 (35.7) 50 (34.0) 0.985 0.611
rs41423247 CC 23 (4.2) 9 (6.1)
CRHR1: N = 696 GR N = 690
Table 2 Genotype distribution for the two polymorphisms and
family history (FH) of mental illness
Gene Genotypes No FH (%) Positive FH (%) χ2 P-value
CRHR1 rs242941 GG 536 (87.0) 63 (78.8)
rs242941 GT 73 (11.9) 17 (21.3) 6.308 0.043
rs242941 TT 7 (1.1) 0 (0.0)
GR rs41423247 GG 368 (60.3) 46 (57.5)
rs41423247 GC 217 (35.6) 27 (33.8) 3.461 0.177
rs41423247 CC 25 (4.1) 7 (8.8)
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BclI SNP and perinatal depression while this CRHR1
SNP is not polymorphic in our population. Engineer et
al. also reported that the G-G-T haplotype of the CRHR1
was significantly over-represented in patients with high
EPDS depression scores. We were not able to do a simi-
lar haplotype analysis because two of the three markers
(CRHR1 rs242939 and rs1876828) were not polymorphic
in our population.
Compared to the study, our cohort has almost five
times the number of study subjects (N = 696 versus N =
140), with higher power to detect a statistically signifi-
cant difference. There are also two major differences be-
tween our study and that of Engineer et al. [31]. One is the
ethnic origin of the population studied. Our cohort com-
prised Chinese women while theirs was a Western popula-
tion. However, the prevalence of antenatal and postnatal
depression in Singapore is similar to the range for Western
population; with no evidence of decreased susceptibility to
perinatal depression in our population. Another difference
between the two studies is the method of classification of
the study subjects. Although both were prospective studies
involving a hospital population, ours is a case-control
design. Controls were screened with EPDS while cases
were patients who had been evaluated by psychiatrists as
meeting DSM IV criteria for depression; whereas Engi-
neer’s cohort were divided into two groups with low versus
high postnatal depression risk. In their study, women who
scored below 10 on the EPDS were placed in the “Low
PND Risk” group and those with EPDS of 10 and above
comprised the “High PND Risk” group. There was no
clinical assessment on the symptoms of the subjects; while
we use EPDS ≤ 7 for controls and clinically diagnosed
depression for cases. As EPDS is a screening rather than a
diagnostic tool, using it to classify the subjects might not
reflect the actual risk status of the patients.
Another group from the UK also attempted to repli-
cate the above findings using an existing cohort. As the
GR SNPs BclI and ER22/23EK (rs41423247 and rs6190
respectively) used in the original study were not available
in the dataset from the genotyping platform used
(Illumina human 660 W-quad genome-wide SNP geno-
typing platform), two other SNPs which are in strong link-
age disequilibrium with the respective SNPs – rs853180
(r2 = 0.965 with rs41423247) and rs10482704 (r2 = 0.793
with rs6190) – were used for analysis. Logistic regression
analysis with EPDS scores as a continuous variable found
no association of any of the five SNPs with EPDS scores at
18 weeks gestation, and weak association of three of the
SNPs (GR rs853180 and rs10482704; CRHR1 rs242939)
with EPDS scores at 8 weeks postnatal. Analysing it as a
binary variable (which was used in ours and Engineer’s
studies) showed similar results [30]. Another group from
Germany also found no association with the BclI SNP or
two other GR SNPS (rs6195 and rs10482605), or two
CRHR1 SNPs (rs110402 and rs7209436) or any haplotype
tested [29].
Although our study on a Chinese population found no
evidence of association of the specific GR and CRHR1
SNPs and risk of pregnancy-related depression in our
population, there was a statistically significant association
with positive family history for CRHR1 rs242941. This
SNP has been found to constitute part of a haplotype
predisposing to depression and anti-depressant respon-
siveness [28, 38, 39].
For GR rs41423247 (BclI), although we found no evi-
dence of association with a diagnosis of perinatal depres-
sion, there was a highly significant association with the
regularity of menstrual cycles. Genotypes containing the
minor allele (C) were more common among patients who
self-reported that their menstrual cycles were not regular.
The variant has been found to be associated with
increased glucocorticoid sensitivity [40, 41]. This genotype
with the C allele and/or C-containing genotypes have also
been found to be associated with depression or higher
depression scores [22, 42–44].
A main limitation of our study is the lack of data
regarding the exact timing of onset of perinatal depres-
sion, whether cases had their onset during pregnancy or
in the postnatal period. However, there is good evidence
for genetic links in depression with onset at both times.
Additionally, there is good evidence of the close link
between antenatal and postnatal onset depression, with
23 – 45 % postnatally depressed women having antenatal
depression [45, 46]. Other limitations were that the pat-
terns of change in menstrual cycle length and mood
symptoms were self-reported and retrospective with
women reporting changes in a typical cycle over the past
12 months.
Conclusions
There is no association between the specific SNPs and
the diagnosis of perinatal depression in this cohort of
Singaporean Chinese patients. However, based on the
our findings on the associations with family history of men-
tal illness and menstrual period regularity, the GR and
CHR1 pathways may still be involved in the predisposition
Table 3 Genotype distribution for the two polymorphisms and
regularity of menstrual cycles
Gene Genotypes Regular (%) Not regular (%) χ2 P-value
CRHR1 rs242941 GG 481 (85.0) 117 (90.7)
rs242941 GT 79 (14.0) 11 (8.5) 2.876 0.237
rs242941 TT 6 (1.1) 1 (0.8)
GR rs41423247 GG 354 (63.2) 59 (45.7)
rs41423247 GC 188 (33.6) 56 (43.4) 21.381 0.000
rs41423247 CC 18 (3.2) 14 (10.9)
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to mental illness, and menstrual period regularity may be
a predisposing factor in susceptible women.
There is a need for more studies in different populations
to find the genetic factors associated with depression during
pregnancy and following delivery. Identification of bio-
markers facilitates screening of at-risk individuals for early
intervention, choice of treatment, prediction of treatment
response, and prognosis of outcome over a wide spectrum
of symptoms associated with affective states, thereby opti-
mizing clinical practice procedures.
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